Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

A Study of Oral Sapacitabine in Elderly Patients With Newly Diagnosed Acute Myeloid Leukemia

ClinicalTrials.gov ID: NCT01303796

Public ClinicalTrials.gov record NCT01303796. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 23, 2026, 6:13 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase III Randomized Study of Oral Sapacitabine in Elderly Patients With Newly Diagnosed Acute Myeloid Leukemia

Study identification

NCT ID
NCT01303796
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Cyclacel Pharmaceuticals, Inc.
Industry
Enrollment
482 participants

Conditions and interventions

Interventions

  • Sapacitabine Drug
  • Decitabine Drug

Drug

Eligibility (public fields only)

Age range
70 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Sep 30, 2011
Primary completion
Dec 14, 2016
Completion
Jul 30, 2017
Last update posted
Jun 21, 2022

2011 – 2017

United States locations

U.S. sites
39
U.S. states
25
U.S. cities
35
Facility City State ZIP Site status
University of Alabama Comprehensive Cancer Center Birmingham Alabama 35294
Scripps Cancer Center La Jolla California 92037
UCLA Ronald Reagan Medical Center Los Angeles California 90095
Norwalk Hospital Norwalk Connecticut 06850
Shands Cancer Hospital at University of Florida Gainesville Florida 32608
Cleveland Clinic Florida Weston Florida 33331
Winship Cancer Institute, Emory University Atlanta Georgia 30322
Blood and Marrow Transplant Group of Georgia Atlanta Georgia 30342
Northwestern Memorial Hospital Chicago Illinois 60611
Rush University Medical Center Chicago Illinois 60612
The University of Chicago Medical Center Chicago Illinois 60637
St. Francis Medical Group Oncology and Hematology Specialists Indianapolis Indiana 46237
University of Iowa Hospitals and Clinics Iowa City Iowa 52242
University of Maryland Greenbaum Cancer Center Baltimore Maryland 21201
Beth Israel Deaconess Medical Center Boston Massachusetts 02215
Henry Ford Health System Detroit Michigan 48202
Mayo Clinic Rochester Minnesota 55905
Saint Luke's Cancer Institute Kansas City Missouri 64111
St. Louis University Cancer Center St Louis Missouri 63110
University of Nebraska Medical Center Omaha Nebraska 68198
Dartmouth - Hitchcock Medical Center Lebanon New Hampshire 03756
John Theurer Cancer Center at the Hackensack University Medical Center Hackensack New Jersey 07601
Westchester Hematology Oncology Group, PC Hawthorne New York 10532
Beth Israel Medical Center New York New York 10003
Memorial Sloan Kettering Cancer Center New York New York 10065
Stony Brook University Medical Center Stony Brook New York 11794
Duke University Medical Center Durham North Carolina 27710
Gabrail Cancer Center Research Canton Ohio 44718
University of Cincinnati Cincinnati Ohio 45267
Cleveland Clinic Foundation Cleveland Ohio 44195
Penn State Milton S. Hershey Medical Center Hershey Pennsylvania 17033
Abramson Cancer Center of the University of Pennsylvania Philadelphia Pennsylvania 19104
Saint Francis Hospital Greenville South Carolina 29601
Vanderbilt University Medical Center Nashville Tennessee 37232
Baylor University Medical Center Dallas Texas 75246
MD Anderson Cancer Center Houston Texas 77030-3387
Joe Arrington Cancer Research and Treatment Center Lubbock Texas 79410
Huntsman Cancer Institute at the University of Utah Salt Lake City Utah 84112
The Medical College of Wisconsin Milwaukee Wisconsin 53226

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 79 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT01303796, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jun 21, 2022 · Synced Jul 23, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT01303796 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →